疾病
帕金森病
多酚
医学
病理
生物
生物化学
抗氧化剂
作者
Sunisha Aryal,Taylor Skinner,Bronwyn Bridges,John T. Weber
出处
期刊:Molecules
[Multidisciplinary Digital Publishing Institute]
日期:2020-09-24
卷期号:25 (19): 4382-4382
被引量:119
标识
DOI:10.3390/molecules25194382
摘要
Parkinson's disease (PD) is a progressive neurodegenerative disorder that is characterized by a loss of dopaminergic neurons, leading to bradykinesia, rigidity, tremor at rest, and postural instability, as well as non-motor symptoms such as olfactory impairment, pain, autonomic dysfunction, impaired sleep, fatigue, and behavioral changes. The pathogenesis of PD is believed to involve oxidative stress, disruption to mitochondria, alterations to the protein α-synuclein, and neuroinflammatory processes. There is currently no cure for the disease. Polyphenols are secondary metabolites of plants, which have shown benefit in several experimental models of PD. Intake of polyphenols through diet is also associated with lower PD risk in humans. In this review, we provide an overview of the pathology of PD and the data supporting the potential neuroprotective capacity of increased polyphenols in the diet. Evidence suggests that the intake of dietary polyphenols may inhibit neurodegeneration and the progression of PD. Polyphenols appear to have a positive effect on the gut microbiome, which may decrease inflammation that contributes to the disease. Therefore, a diet rich in polyphenols may decrease the symptoms and increase quality of life in PD patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI